About Ultromics
Ultromics is a company based in Oxford (United Kingdom) founded in 2017 by Ross Upton and Paul Leeson.. Ultromics has raised $115.57 million across 7 funding rounds from investors including University of Oxford, Legal & General and Lightrock. Ultromics operates in a competitive market with competitors including Tricog, Fifth Eye, Rhythm AI, CardioLogs and Ligence, among others.
- Headquarter Oxford, United Kingdom
- Founders Ross Upton, Paul Leeson
- Stage Minicorn
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Ultromics Limited
- Date of Incorporation 22 Mar, 2017
- Jurisdiction OXFORD, OXFORDSHIRE, UNITED KINGDOM
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$115.57 M (USD)
in 7 rounds
-
Latest Funding Round
-
Investors
University of Oxford
& 16 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of Ultromics
Ultromics has successfully raised a total of $115.57M across 7 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Last Round
-
First Round
First Round
(18 May 2017)
- Investors Count 17
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2025 | Amount | Series C - Ultromics | Valuation | American Heart Association |
|
| Jul, 2025 | Amount | Series C - Ultromics | Valuation | AllegisCyber Capital , Legal & General | |
| Aug, 2021 | Amount | Series B - Ultromics | Valuation | BVF |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Ultromics
Ultromics has secured backing from 17 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include University of Oxford, Legal & General and Lightrock. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Funding is provided to healthcare startups by corporate-backed BVF.
|
Founded Year | Domain | Location | |
|
Corporate backed venture capital fund investing in multiple sectors
|
Founded Year | Domain | Location | |
|
Early-stage tech and offline focused VC firm funding companies in the US
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Ultromics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Ultromics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Ultromics Comparisons
Competitors of Ultromics
Ultromics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tricog, Fifth Eye, Rhythm AI, CardioLogs and Ligence, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
AI-powered cardiac diagnostic solutions are provided for care pathways.
|
|
| domain | founded_year | HQ Location |
An analytics platform for managing hemodynamic instability is provided.
|
|
| domain | founded_year | HQ Location |
AI-based platform for cardiac disease diagnosis is provided.
|
|
| domain | founded_year | HQ Location |
Automated ECG interpretation is used for cardiovascular screening.
|
|
| domain | founded_year | HQ Location |
AI-based 2D echocardiography is provided for heart ultrasound analysis.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Ultromics
Frequently Asked Questions about Ultromics
When was Ultromics founded?
Ultromics was founded in 2017.
Where is Ultromics located?
Ultromics is headquartered in Oxford, United Kingdom. It is registered at Oxford, Oxfordshire, United Kingdom.
Who is the current CEO of Ultromics?
Ross Upton is the current CEO of Ultromics. They have also founded this company.
Is Ultromics a funded company?
Ultromics is a funded company, having raised a total of $115.57M across 7 funding rounds to date. The company's 1st funding round was a Series B of $33M, raised on May 18, 2017.
What does Ultromics do?
Ultromics was established in 2017 in Oxford, United Kingdom, within the health technology sector. Software named EchoGo is developed to process echocardiography images and detect cardiovascular conditions. Data points such as structural and functional metrics are extracted from individual scans by its AI engine. Diagnostic precision for coronary heart disease is improved through this automated analysis, supporting clinical workflows in cardiology.
Who are the top competitors of Ultromics?
Ultromics's top competitors include Tricog, Fifth Eye and VentriJect.
Who are Ultromics's investors?
Ultromics has 17 investors. Key investors include University of Oxford, Legal & General, Lightrock, BVF, and Google Ventures.
What is Ultromics's valuation?
The valuation of Ultromics is $49.7M as of Sep 2020.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.